Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease.

Garlo KG, Steele DJR, Nigwekar SU, Chan KE.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):125-136. doi: 10.2215/CJN.06430518. Epub 2018 Dec 28.

PMID:
30593489
2.

Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital.

Chan KE, Chedgy E, Bent CL, Turner KJ.

Ann R Coll Surg Engl. 2018 Jul;100(6):480-484. doi: 10.1308/rcsann.2018.0040. Epub 2018 Apr 16.

3.

Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.

Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S.

Am J Kidney Dis. 2018 Jul;72(1):75-83. doi: 10.1053/j.ajkd.2017.11.018. Epub 2018 Feb 9.

PMID:
29429751
4.

Urinary Stone Disease and Cardiovascular Disease Risk in a Rural Chinese Population.

Fan X, Kalim S, Ye W, Zhao S, Ma J, Nigwekar SU, Chan KE, Cui J, Cai J, Wang L, Heng W, Zhou Y, Sun Y, Cui R, Zhang W, Wang B, Dai Q, Li X, Thadhani R, Li X.

Kidney Int Rep. 2017 Jun 8;2(6):1042-1049. doi: 10.1016/j.ekir.2017.06.001. eCollection 2017 Nov.

5.

Temporal characterization and statistical analysis of flowback and produced waters and their potential for reuse.

Oetjen K, Chan KE, Gulmark K, Christensen JH, Blotevogel J, Borch T, Spear JR, Cath TY, Higgins CP.

Sci Total Environ. 2018 Apr 1;619-620:654-664. doi: 10.1016/j.scitotenv.2017.11.078. Epub 2017 Nov 29.

PMID:
29156284
6.

Fluorescent nucleobases as tools for studying DNA and RNA.

Xu W, Chan KM, Kool ET.

Nat Chem. 2017 Nov;9(11):1043-1055. doi: 10.1038/nchem.2859. Epub 2017 Oct 16. Review.

7.

Luminescent Carbon Dot Mimics Assembled on DNA.

Chan KM, Xu W, Kwon H, Kietrys AM, Kool ET.

J Am Chem Soc. 2017 Sep 20;139(37):13147-13155. doi: 10.1021/jacs.7b07420. Epub 2017 Sep 12.

8.

Warfarin, Atrial Fibrillation, and CKD: Effective and Safe, but Soon Extinct?

Larkin JW, Chan KE.

Am J Kidney Dis. 2017 Jun;69(6):720-722. doi: 10.1053/j.ajkd.2017.01.007. No abstract available.

PMID:
28532634
9.

Color-Change Photoswitching of an Alkynylpyrene Excimer Dye.

Chan KM, Kölmel DK, Wang S, Kool ET.

Angew Chem Int Ed Engl. 2017 Jun 1;56(23):6497-6501. doi: 10.1002/anie.201701235. Epub 2017 May 5.

10.

More monitoring: Non-vitamin K-dependent oral anticoagulant agent use in chronic kidney disease patients.

Khoury CC, Chan KE.

Am Heart J. 2017 Feb;184:148-149. doi: 10.1016/j.ahj.2016.10.023. Epub 2016 Nov 4. No abstract available.

PMID:
28224929
11.

DNA as an environmental sensor: detection and identification of pesticide contaminants in water with fluorescent nucleobases.

Kwon H, Chan KM, Kool ET.

Org Biomol Chem. 2017 Feb 22;15(8):1801-1809. doi: 10.1039/c6ob02830f.

12.

Correction to "Genetically Encoded Multispectral Labeling of Proteins with Polyfluorophores on a DNA Backbone".

Singh V, Wang S, Chan KM, Clark SA, Kool ET.

J Am Chem Soc. 2017 Feb 8;139(5):2118. doi: 10.1021/jacs.6b11085. Epub 2017 Jan 27. No abstract available.

PMID:
28128555
13.

A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.

Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE.

J Am Soc Nephrol. 2016 Nov;27(11):3421-3429. Epub 2016 Apr 14.

14.

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

Chan KE, Giugliano RP, Patel MR, Abramson S, Jardine M, Zhao S, Perkovic V, Maddux FW, Piccini JP.

J Am Coll Cardiol. 2016 Jun 21;67(24):2888-99. doi: 10.1016/j.jacc.2016.02.082. Review. Erratum in: J Am Coll Cardiol. 2016 Dec 27;68(25):2920.

15.

The impact of cardiopulmonary exercise testing on patients over the age of 80 undergoing elective colorectal cancer surgery.

Chan KE, Pathak S, Smart NJ, Batchelor N, Daniels IR.

Colorectal Dis. 2016 Jun;18(6):578-85. doi: 10.1111/codi.13139.

PMID:
26417705
16.

The Wessex wrap circumcision dressing.

Chan KE, Chedgy EC, Turner K.

Ann R Coll Surg Engl. 2015 Oct;97(7):542. doi: 10.1308/rcsann.2015.0033.2. No abstract available.

17.

In Vitro Fluorogenic Real-Time Assay of the Repair of Oxidative DNA Damage.

Edwards SK, Ono T, Wang S, Jiang W, Franzini RM, Jung JW, Chan KM, Kool ET.

Chembiochem. 2015 Jul 27;16(11):1637-46. doi: 10.1002/cbic.201500184. Epub 2015 Jun 12.

18.

Heritability of Risk for Sudden Cardiac Arrest in ESRD.

Chan KE, Newton-Cheh C, Gusella JF, Maddux FW.

J Am Soc Nephrol. 2015 Nov;26(11):2815-20. doi: 10.1681/ASN.2014090881. Epub 2015 Apr 16.

19.

Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW.

Circulation. 2015 Mar 17;131(11):972-9. doi: 10.1161/CIRCULATIONAHA.114.014113. Epub 2015 Jan 16.

20.

Adherence barriers to chronic dialysis in the United States.

Chan KE, Thadhani RI, Maddux FW.

J Am Soc Nephrol. 2014 Nov;25(11):2642-8. doi: 10.1681/ASN.2013111160. Epub 2014 Apr 24.

21.

Surgical outcomes following resection for sporadic abdominal wall fibromatosis.

Wilkinson MJ, Chan KE, Hayes AJ, Strauss DC.

Ann Surg Oncol. 2014 Jul;21(7):2144-9. doi: 10.1245/s10434-014-3618-5. Epub 2014 Mar 7.

PMID:
24604586
22.

Fast alpha nucleophiles: structures that undergo rapid hydrazone/oxime formation at neutral pH.

Kool ET, Crisalli P, Chan KM.

Org Lett. 2014 Mar 7;16(5):1454-7. doi: 10.1021/ol500262y. Epub 2014 Feb 21.

23.

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease.

Chan KE, Thadhani RI, Maddux FW.

Kidney Int. 2013 Sep;84(3):555-61. doi: 10.1038/ki.2013.152. Epub 2013 May 15.

24.

Genetically encoded multispectral labeling of proteins with polyfluorophores on a DNA backbone.

Singh V, Wang S, Chan KM, Clark SA, Kool ET.

J Am Chem Soc. 2013 Apr 24;135(16):6184-91. doi: 10.1021/ja4004393. Epub 2013 Apr 16. Erratum in: J Am Chem Soc. 2017 Feb 8;139(5):2118.

25.

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, Hakim RM.

J Am Soc Nephrol. 2012 Sep;23(9):1551-9. doi: 10.1681/ASN.2012010050. Epub 2012 Aug 16.

26.

RightReturn. Partnering to reduce the high rate of hospital readmission for dialysis-dependent patients.

Wingard RL, Chan KE, Hakim R.

Nephrol News Issues. 2012 Mar;26(3):20-2.

PMID:
22479972
27.

Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

Chan KE, Pflederer TA, Steele DJ, Lilly MP, Ikizler TA, Maddux FW, Hakim RM.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2669-80. doi: 10.2215/CJN.02860311. Epub 2011 Sep 29.

28.

Early outcomes among those initiating chronic dialysis in the United States.

Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2642-9. doi: 10.2215/CJN.03680411. Epub 2011 Sep 29.

29.

Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.

Chan KE, Ikizler TA, Gamboa JL, Yu C, Hakim RM, Brown NJ.

Kidney Int. 2011 Nov;80(9):978-985. doi: 10.1038/ki.2011.228. Epub 2011 Jul 20.

30.

Digoxin associates with mortality in ESRD.

Chan KE, Lazarus JM, Hakim RM.

J Am Soc Nephrol. 2010 Sep;21(9):1550-9. doi: 10.1681/ASN.2009101047. Epub 2010 Jun 24.

31.

Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.

Chan KE, Thadhani R, Lazarus JM, Hakim RM.

Clin J Am Soc Nephrol. 2010 May;5(5):856-66. doi: 10.2215/CJN.07161009. Epub 2010 Mar 25.

32.

The "right" of passage: surviving the first year of dialysis.

Wingard RL, Chan KE, Lazarus JM, Hakim RM.

Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S114-20. doi: 10.2215/CJN.04360709.

33.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Chan KE, Lazarus JM, Thadhani R, Hakim RM.

J Am Soc Nephrol. 2009 Oct;20(10):2223-33. doi: 10.1681/ASN.2009030319. Epub 2009 Aug 27.

34.

Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge.

Chan KE, Lazarus JM, Wingard RL, Hakim RM.

Kidney Int. 2009 Aug;76(3):331-41. doi: 10.1038/ki.2009.199. Epub 2009 Jun 10.

35.

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Chan KE, Lazarus JM, Thadhani R, Hakim RM.

J Am Soc Nephrol. 2009 Apr;20(4):872-81. doi: 10.1681/ASN.2008080824. Epub 2009 Mar 18.

36.

Renal transplants: what ultrasound can and cannot do.

Cosgrove DO, Chan KE.

Ultrasound Q. 2008 Jun;24(2):77-87; quiz 141-2. doi: 10.1097/RUQ.0b013e31817c5e46. Review.

PMID:
18528243
37.

Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients.

Chan KE, Lafayette RA, Whittemore AS, Hlatky MA, Moran J.

Nephrol Dial Transplant. 2008 Sep;23(9):2948-56. doi: 10.1093/ndt/gfn172. Epub 2008 May 9.

PMID:
18469314
38.

Synchronization and coarsening (without self-organized criticality) in a forest-fire model.

Chan KE, Krapivsky PL, Redner S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Jul;66(1 Pt 2):016122. Epub 2002 Jul 24.

PMID:
12241441
39.
40.
41.

Primary carcinoma and benign tumours of the female breast in Malaysian women.

Chan KE.

Med J Malaysia. 1982 Sep;37(3):217-20. No abstract available.

PMID:
7177001
42.

Bleeding after Malayan pit viper bites.

Chan KE.

Southeast Asian J Trop Med Public Health. 1979 Jun;10(2):276-9. No abstract available.

PMID:
524154
43.
44.

Treatment of urinary infection with co-trimoxazole (trimethoprim-sulphamethoxazole).

Gong NC, Chan KE, Singham KT, Chai KH.

Med J Malaysia. 1974 Mar;28(3):194-6. No abstract available.

PMID:
4278358
45.

The pre-junctional site of action of Enhydrina schistosa venom at the neuromuscular junction.

Geh SL, Chan KE.

Eur J Pharmacol. 1973 Feb;21(2):115-20. No abstract available.

PMID:
4696097
46.

Relation between the haemorrhagic and anti-thrombotic action of heparin and warfarin in arterial thrombosis.

Chan KE.

Cardiovasc Res. 1972 May;6(3):248-56. No abstract available.

PMID:
5035594
47.

Normal ganglionic transmission in the presence of acetylcholine block by sea snake (Enhydrina schistosa) venom.

Chan KE, Chang P.

Eur J Pharmacol. 1971 Jan;13(2):277-9. No abstract available.

PMID:
5544083
48.

Cardiovascular effects of 2-(O-chlorophenyl)-2-methylaminocyclohexanone (CI-581) in rats.

Chang P, Chan KE, Ganendran A.

Br J Anaesth. 1969 May;41(5):391-5. No abstract available.

49.
50.

The modification of experimental occlusive arterial thrombosis in the rat by Malayan pit viper venom.

Chan KE.

Thromb Diath Haemorrh. 1968 Mar 31;19(1):242-7. No abstract available.

PMID:
5652231

Supplemental Content

Loading ...
Support Center